CDRUPTEV
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Jul 2022)
What this means for you
This application is over — abandoned 25 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90254990
- Mark type
- Stylized text
- Filed
- 14 Oct 2020
- Published for opposition
- 27 Apr 2021
- Abandoned
- 25 Jul 2022
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community
Owner
- Seres Therapeutics, Inc., Cambridge, MA, US
- Seres Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 25 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 25 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2021 — SOU EXTENSION 1 GRANTED
- 08 Dec 2021 — SOU EXTENSION 1 FILED
- 08 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Apr 2021 — PUBLISHED FOR OPPOSITION
- 07 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2021 — ASSIGNED TO EXAMINER
- 02 Dec 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2020 — NEW APPLICATION ENTERED